Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) comprises around 6% of all non-Hodgkin’s lymphoma (NHL) diagnoses. In younger patients, age less than 60 to 65 years, aggressive induction often followed by consolidation with autologous stem cell transplant has suggested improved outcomes in this population. Less intensiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Spurgeon, Stephen E., Till, Brian G., Martin, Peter, Goy, Andre H., Dreyling, Martin P., Gopal, Ajay K., LeBlanc, Michael, Leonard, John P., Friedberg, Jonathan W., Baizer, Lawrence, Little, Richard F., Kahl, Brad S., Smith, Mitchell R.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059122/
https://ncbi.nlm.nih.gov/pubmed/28040733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados